TORONTO, July 07, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has acquired (the “Acquisition”) Novari Health Inc. (“Novari”), a leading healthcare software provider of patient flow solutions based in Canada. Transaction Details VitalHub has acquired Novari for total up-front consideration of $43.6 million, plus potential performance-based consideration. The purchase price paid at closing was composed of a cash payment of $35.8 ...

Core Points - Vitalhub Corp. held its annual general meeting on June 27, 2025, where all director nominees were elected and MNP LLP was appointed as auditors [1][3] Voting Results - Total shares voted were 33,721,314, representing 60.45% of the total shares issued and outstanding, which is 55,784,972 [1] - Election of Directors: - Barry Tissenbaum received 27,796,480 votes (83.01%) - Roger Dent received 22,227,480 votes (66.38%) - Stephen Garrington received 33,334,105 votes (99.55%) - Dan Matlow received 33,209,025 votes (99.18%) - Francis Shen received 24,660,909 votes (73.65%) - Tony Shen received 27,960,184 votes (83.50%) [2] - Appointment of Auditors: - MNP LLP received 33,564,368 votes (99.53%) for appointment as auditors [4] Company Overview - VitalHub is a leading software company focused on health and human services, offering a product suite that includes electronic health records and operational intelligence [5] - The company serves over 1,000 clients across the UK, Canada, and other regions, and has a growth strategy that includes both organic opportunities and an aggressive M&A plan [5]

Acquisition Overview - VitalHub Corp. has completed the cash acquisition of Induction Healthcare Group PLC through a court-sanctioned scheme of arrangement, valuing Induction at approximately £9.7 million [1][4] - The acquisition price was £0.10 in cash for each Induction share [4] Induction's Business and Financials - Induction provides software solutions that enhance care delivery and patient journeys in hospitals, with key products including Zesty and Attend Anywhere [3][6] - For the six-month period ending September 30, 2024, Induction reported revenues of £5.4 million, a gross margin of 78.2%, and an adjusted EBITDA loss of £0.9 million [4] - Zesty generated revenues of £2.0 million, while Attend Anywhere generated revenues of £3.2 million, with £0.2 million from discontinued operations [4] - As of the acquisition closing date, Zesty had an Annual Recurring Revenue (ARR) of £2.2 million, and Attend Anywhere had virtual care recurring revenue of £4.6 million [4][14] Strategic Rationale - The CEO of VitalHub stated that the Induction product set, particularly the Zesty platform, is highly complementary to VitalHub's existing solutions, aiming to enhance value for healthcare partners and improve patient outcomes [5] - VitalHub's growth strategy includes targeting organic opportunities and pursuing an aggressive M&A plan [5]

Core Viewpoint - VitalHub Corp. has filed a preliminary short form base shelf prospectus allowing for the potential distribution of up to $250 million in various securities over a 25-month period once finalized [1][2]. Group 1: Base Shelf Prospectus Details - The base shelf prospectus will enable the company to qualify the distribution of common shares, debt securities, warrants, subscription receipts, units, or any combination thereof [2]. - The specific terms of any offering will be established in a prospectus supplement, which will be filed with Canadian securities regulatory authorities [2][3]. - No securities can be sold or offers accepted until a receipt for the final base shelf prospectus is obtained [3]. Group 2: Company Overview - VitalHub is a leading software company focused on health and human services, serving over 1,000 clients globally [5]. - The company has a growth strategy that includes organic opportunities and an aggressive M&A plan [5]. - VitalHub is headquartered in Toronto and employs over 500 people worldwide, including a dedicated Innovations Lab in Sri Lanka [5].

Annual Recurring Revenue (ARR)⁽¹⁾ up 54% YoY to $73.7 millionTotal Revenue up 42% YoY to $21.7 millionAdjusted EBITDA⁽¹⁾ up 39% YoY to $5.6 million TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX: VHIBF) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and Analysis report for the three months ended March 31, 2025 with the Canadian securities authorities. These documents may be viewed unde ...

[Financial Highlights](index=1&type=section&id=Financial%20Highlights) Valhi, Inc. reported strong Q1 2025 financial results, highlighted by a significant increase in net income and improved segment performance [Overall Performance](index=1&type=section&id=Overall%20Performance) Valhi, Inc. reported a significant increase in net income for the first quarter of 2025, reaching $16.9 million, more than double the $7.8 million from the same period in 2024, primarily driven by stronger operating results in the Chemicals Segment Q1 2025 vs Q1 2024 Performance Summary | Metric | Q1 2025 | Q1 2024 | Change | | :--- | :--- | :--- | :--- | | Net Income Attributable to Valhi Stockholders | $16.9 million | $7.8 million | +116.7% | | Diluted EPS | $0.59 | $0.27 | +118.5% | - The increase in net income was primarily due to higher operating results from the Chemicals Segment[1](index=1&type=chunk) - Effective July 16, 2024, the Chemicals Segment acquired the remaining 50% of Louisiana Pigment Company, L.P. (LPC), making it a wholly-owned subsidiary, with LPC's results included in the consolidated financials from the acquisition date[1](index=1&type=chunk) [Segment Performance](index=1&type=section&id=Segment%20Performance) Analysis of Valhi's business segments reveals varied performance, with strong growth in Chemicals and Component Products offsetting declines in Real Estate [Chemicals Segment](index=1&type=section&id=Chemicals%20Segment) The Chemicals Segment's net sales rose by 2% to $489.8 million in Q1 2025, driven by higher sales volumes in North America and Europe and increased TiO2 prices, while operating income surged by 80.7% to $41.2 million due to higher production volumes, improved pricing, and lower per-ton production costs Chemicals Segment Financials (Q1 2025 vs Q1 2024) | Metric | Q1 2025 | Q1 2024 | Change | | :--- | :--- | :--- | :--- | | Net Sales | $489.8 M | $478.8 M | +2.3% | | Operating Income | $41.2 M | $22.8 M | +80.7% | - Net sales increased due to higher sales volumes in North American and European markets and **2% higher average TiO2 selling prices**, partially offset by lower export volumes and an **$11 million negative impact** from currency fluctuations[2](index=2&type=chunk) - Operating income growth was driven by higher sales and production volumes, higher prices, and lower per-metric-ton production costs, with TiO2 production volumes **18% higher** than in Q1 2024[3](index=3&type=chunk) - The segment operated at **93% of average capacity** in Q1 2025, up from **87%** in Q1 2024[3](index=3&type=chunk) [Component Products Segment](index=1&type=section&id=Component%20Products%20Segment) The Component Products Segment saw net sales increase to $40.3 million and operating income rise to $5.9 million in Q1 2025, primarily attributed to higher sales of marine components to the towboat and government markets, along with increased sales of security products to the government security market Component Products Segment Financials (Q1 2025 vs Q1 2024) | Metric | Q1 2025 | Q1 2024 | Change | | :--- | :--- | :--- | :--- | | Net Sales | $40.3 M | $38.0 M | +6.1% | | Operating Income | $5.9 M | $3.7 M | +59.5% | - The increase in sales and operating income was driven by higher marine components sales (to towboat and government markets) and higher security products sales (to the government security market)[4](index=4&type=chunk) [Real Estate Management and Development Segment](index=1&type=section&id=Real%20Estate%20Management%20and%20Development%20Segment) This segment experienced a significant decline in performance, with net sales dropping to $8.5 million from $13.8 million in the prior-year quarter, linked to a slower pace of development activities caused by delays in obtaining city permits and environmental approvals Real Estate Segment Financials (Q1 2025 vs Q1 2024) | Metric | Q1 2025 | Q1 2024 | Change | | :--- | :--- | :--- | :--- | | Net Sales | $8.5 M | $13.8 M | -38.4% | | Operating Income | $3.0 M | $5.0 M | -40.0% | - Land sales revenue is recognized over time based on development spending, and revenue declined due to a slower pace of development activities[5](index=5&type=chunk) - Development has been slowed by delays in obtaining city permits and environmental approvals from the Nevada Department of Environmental Protection[6](index=6&type=chunk) [Corporate Items and Expenses](index=3&type=section&id=Corporate%20Items%20and%20Expenses) Corporate financials show stable expenses but increased interest costs due to higher debt levels [Summary of Corporate-Level Financials](index=3&type=section&id=Summary%20of%20Corporate-Level%20Financials) In Q1 2025, corporate expenses remained stable compared to the previous year, however, interest income decreased by $1.4 million due to lower interest rates and cash balances, while interest expense rose by $1.9 million, primarily because of higher debt levels at the Chemicals Segment from transactions in 2024 - Corporate expenses were comparable between Q1 2025 and Q1 2024[7](index=7&type=chunk) - Interest income and other decreased by **$1.4 million** due to lower average interest rates and decreased cash balances[7](index=7&type=chunk) - Interest expense increased by **$1.9 million**, mainly due to higher overall debt levels resulting from the Chemicals Segment's debt transactions in 2024[7](index=7&type=chunk) [Forward-Looking Statements and Risk Factors](index=3&type=section&id=Forward-Looking%20Statements%20and%20Risk%20Factors) The report outlines significant risks and uncertainties that could impact future financial performance [Risk Disclosure](index=3&type=section&id=Risk%20Disclosure) The report includes forward-looking statements based on current management beliefs, which are subject to substantial risks and uncertainties, with numerous factors identified that could cause actual results to differ materially, including market supply and demand, raw material costs, global economic conditions, operational interruptions, currency fluctuations, and regulatory changes - The report contains forward-looking statements that are not historical facts and involve substantial risks and uncertainties[8](index=8&type=chunk) - Key risk factors include: * Future supply and demand for products like TiO2 * Changes in raw material and operating costs (ore, energy) * General global economic and political conditions * Operating interruptions, including labor disputes, natural disasters, and cyber-attacks * Fluctuations in currency exchange rates (USD vs. euro, Norwegian krone, Canadian dollar) * Environmental matters and changes in government laws and regulations[8](index=8&type=chunk)[11](index=11&type=chunk) [Financial Statements](index=7&type=section&id=Financial%20Statements) Detailed financial statements provide a comprehensive overview of income and key segment performance drivers [Condensed Summary of Income](index=7&type=section&id=Condensed%20Summary%20of%20Income) For the first quarter of 2025, Valhi's total net sales grew to $538.6 million from $530.6 million year-over-year, total operating income increased significantly to $50.1 million from $31.5 million, and after accounting for corporate items and taxes, net income attributable to stockholders was $16.9 million, or $0.59 per share, a substantial increase from $7.8 million, or $0.27 per share, in Q1 2024 Condensed Summary of Income (In millions, except per share) | | Three months ended March 31, | | | :--- | :--- | :--- | | | **2024** | **2025** | | **Total net sales** | **$530.6** | **$538.6** | | **Total operating income** | **$31.5** | **$50.1** | | Income before income taxes | $18.0 | $30.8 | | Net income | $13.6 | $22.8 | | **Net income attributable to Valhi stockholders** | **$7.8** | **$16.9** | | **Basic and diluted net income per share** | **$0.27** | **$0.59** | [Impact of Percentage Change in Chemical Segment's Net Sales](index=8&type=section&id=Impact%20of%20Percentage%20Change%20in%20Chemical%20Segment%27s%20Net%20Sales) The 2% net sales growth in the Chemicals Segment for Q1 2025 was a result of positive and negative factors, with a 5% increase from TiO2 sales volumes and a 2% increase from pricing being the primary drivers, partially offset by a 2% negative impact from product mix/other factors and a 3% negative impact from currency exchange rates Drivers of Chemical Segment's Net Sales Change (Q1 2025 vs Q1 2024) | Factor | Percentage Change | | :--- | :--- | | TiO2 sales volumes | 5% | | TiO2 product pricing | 2% | | TiO2 product mix/other | (2%) | | Changes in currency exchange rates | (3%) | | **Total** | **2%** |

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR (Exact name of Registrant as specified in its charter) Delaware 87-0110150 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 5430 LBJ Freeway, Suite 1700 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EX ...

Dallas, Texas, May 08, 2025 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $16.9 million, or $.59 per share, in the first quarter of 2025 compared to net income of $7.8 million, or $.27 per share, in the first quarter of 2024. Net income attributable to Valhi stockholders increased in the first quarter of 2025 as compared to the first quarter of 2024 primarily due to higher operating results from the Chemicals Segment. As previously reported, effective ...

Core Viewpoint - VitalHub Corp. is set to release its financial results for Q1 2025 on May 8, 2025, followed by a conference call on May 9, 2025, hosted by CEO Dan Matlow and CFO Brian Goffenberg [1] Company Overview - VitalHub is a leading software company focused on empowering health and human services providers globally [2] - The company offers a comprehensive product suite that includes electronic health records, operational intelligence, and workforce automation solutions, serving over 1,000 clients across the UK, Canada, and other regions [2] - VitalHub employs over 500 individuals globally and has a dedicated Innovations Lab located in Sri Lanka [2] - The company has a robust growth strategy that includes targeting organic opportunities within its product suite and pursuing an aggressive M&A plan [2]

Dallas, Texas, April 15, 2025 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE:  VHI) announced today that, subject to the completion of quarter-end closing procedures, it expects to report first quarter 2025 earnings in a press release after market close on Thursday, May 8, 2025.  Valhi, Inc. is engaged in the chemicals (TiO2), component products (security products and recreational marine components) and real estate management and development industries. * * * * * Investor Relations Contact Bryan A. HanleySenior Vic ...